CCL13



CCL13

F1FF1N2NN2P3PP3Q4QQ4G5GG5L6LL6A7AA7Q8QQ8P9PP9D10DD10A11AA11L12LL12N13NN13V14VV14P15PP15S16SS16T17TT17C18CC18C19CC19F20FF20T21TT21F22FF22S23SS23S24SS24K25KK25K26KK26I27II27S28SS28L29LL29Q30QQ30R31RR31L32LL32K33KK33S34SS34Y35YY35V36VV36I37II37T38TT38T39TT39S40SS40R41RR41C42CC42P43PP43Q44QQ44K45KK45A46AA46V47VV47... and 35 more residue(s)...... and 35 more residue(s)

SMILES None
InChIKey None
Sequence FNPQGLAQPDALNVPSTCCFTFSSKKISLQRLKSYVITTSRCPQKAVIFRTKLGKEICADPKEKWVQNYMKHLGRKAHTLKT

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



Bioactivities

CCL13

F1FF1N2NN2P3PP3Q4QQ4G5GG5L6LL6A7AA7Q8QQ8P9PP9D10DD10A11AA11L12LL12N13NN13V14VV14P15PP15S16SS16T17TT17C18CC18C19CC19F20FF20T21TT21F22FF22S23SS23S24SS24K25KK25K26KK26I27II27S28SS28L29LL29Q30QQ30R31RR31L32LL32K33KK33S34SS34Y35YY35V36VV36I37II37T38TT38T39TT39S40SS40R41RR41C42CC42P43PP43Q44QQ44K45KK45A46AA46V47VV47... and 35 more residue(s)...... and 35 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.